IRCT20161212031362N4招募中3 期
Assessing the effect of Fampridine on cognitive outcome measures in multiple sclerosis patients: A double-blind, randomized, placebo-controlled study
Iranian Center of Neurological Research0 个研究点目标入组 108 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Definite MS diagnosis according to McDonald 2017 criteria
- •Age between 18-60 years
- •SDMT score below the 20th percentile of normative values
排除标准
- •History of relapse within 2 months
- •History of seizure/epilepsy
- •History of major depression or psychosis
- •Reluctance to enroll in the study
- •Moderate or higher renal dysfunction (eGFR=< 50mL/min/1.73m2)
研究者
相似试验
尚未招募
2 期
Famotidine for the improvement of cognitive impairments in COVID-19 patientsCOVID-19.COVID-19, virus identifiedU07.1IRCT20090117001556N138Tehran University of Medical Sciences50
尚未招募
1 期
The effect of fampiridine on optic nerve imaging in patients with Anterior Ischemic Optic neuropathyIschemic optic neuropathyIRCT20151123025202N35Shahid Beheshti University of Medical Sciences40
招募中
3 期
Fampridine effect on Parkinson disease symptomsParkinson's diseaseParkinson disease.IRCT20230905059361N1Shahre-kord University of Medical Sciences62
已完成
不适用
Effects of modafinil on cognitive functions in normal subjects using fMRIhealthy adultsJPRN-UMIN000007324ippon Medical School25
招募中
3 期
The effect of famotidine on reducing the side effects of prostate cancer radiotherapyIRCT20231121060132N1Kermanshah University of Medical Sciences50